AAD 2026Abstract 72709Clinical trial
LP-003 Significantly Decreases Chronic Spontaneous Urticaria Disease Activity and is Well Tolerated
Top Line Results from a Phase 2 Trial
Gao X, Hu F, Wu L, Han C, Yang J, Liu H, Zhu R, Zhi Y
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Urticaria
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.1176 · Not in PubMed: details from Crossref